No Data
No Data
Emerging market prospects: Circulatory selection within the biotechnology sector is booming, but the improvement of investor sentiment depends on timing.
Due to the downturn in high-tech stocks and the appreciation of the yen in the foreign markets, investor sentiment has worsened, leading to a significant drop in the emerging markets this week. During the same period, while the Nikkei Average fell by -5.98%, the growth market index fell by -4.50% and the growth market 250 index fell by -4.86%, experiencing a sharp decline. Like the main board market, investor sentiment has also soured in response to the decline of high-tech stocks and the appreciation of the yen in the foreign markets. This has led to a stronger selling pressure, particularly in bio stocks that had been rapidly rising. This is the market trend of the week.
The Tokyo Stock Exchange's Growth Market 250 Index rebounded for the third day and was in a firm condition in comparison to large-cap stocks.
The Tokyo Stock Exchange Growth Market Index was 828.76, up 2.40, with a volume of 0.2 billion and 52.74 million shares traded, and a turnover of 152.3 billion yen. The TSE Growth Market 250 Index was 642.91, up 2.35, with a volume of 0.1 billion and 47.2 million shares traded, and a turnover of 65.8 billion yen. Today's Growth Market saw a rebound in both the TSE Growth Market Index and the TSE Growth Market 250 Index, both up for the first time in three days. The number of rising stocks was 262, the number of declining stocks was 281, and the number of unchanged stocks was 40. The US stock market on the 25th was mixed. The Dow Average was up 81.20 dollars.
The Tokyo Stock Exchange's 250 Gross Market Index fell sharply and expanded its decline due to the pullback of large cap stocks, although it rebounded.
Tokyo Stock Exchange growth market index is at 836.81, down 14.26, with a volume of 98.64 million shares and a turnover of JPY 132.1 billion. Tokyo Stock Exchange Growth Market 250 Index is at 648.21, down 12.69, with a volume of 62.32 million shares and a turnover of JPY 90.3 billion. Today's growth market saw significant declines in both the Tokyo Stock Exchange growth market index and the Tokyo Stock Exchange Growth Market 250 Index. There were 144 advancing stocks, 412 declining stocks, and 28 unchanged stocks. On the 23rd, the US stock market fell, with the Dow Jones Industrial Average dropping by 57.35 dollars.
Japan is doing well with purchases from Chinese travelers at LVMH.
In the second quarter, the revenue of LVMH Moet Hennessy Louis Vuitton, a high-end brand including China, decreased sharply by 14%. The downturn in China was partially offset by the strong purchasing power of Chinese travelers abroad, and sales in Japan were particularly strong. <3660> I-Style <5261> Risol Holdings <8202> LaOX <7532> Don Quijote H <3179> Shuppin <4917>
One step forward, one step back, approaching 700 points at one point.
Overview of last week: July 15-19, the high, low, and closing prices of the Tokyo Growth Index were 697.56, 678.71, and 675.73, respectively, with a weekly decrease of 0.21%. There was a see-saw pattern and the index approached 700 points at one point. The continued rise of the Russell 2000 Index in the United States stimulated buying mainly in major stocks and biotech-related stocks. Although the index approached 700 points during the middle of the week, investor confidence decreased due to the worldwide decline of semiconductor stocks. Profit-taking was prevalent at the end of the week, resulting in weekly decrease in the market.
Emerging market outlook: Pay attention to the battle of the growth 250 index on the 200-day line and the trend of the bio-related stock that plummeted over the weekend.
Despite the dominance of buying, emerging markets saw a slight decline on a weekly basis. During the same period, while the Nikkei Average fell by -2.74%, the growth market index fell by -0.10% and the growth market 250 index fell by -0.21%, making the emerging markets a steady market. After the holidays, the Russell 2000 index, which is composed mainly of small and medium-sized companies on the US market, continued to rise, which stimulated buying of leading stocks in the growth market and bio-related stocks. Tokyo Stock Exchange
No Data